TY - JOUR
T1 - Comprehensive study of 28 individuals with SIN3A-related disorder underscoring the associated mild cognitive and distinctive facial phenotype
AU - Balasubramanian, Meena
AU - Dingemans, Alexander J.M.
AU - Albaba, Shadi
AU - Richardson, Ruth
AU - Yates, Thabo M.
AU - Cox, Helen
AU - Douzgou, Sofia
AU - Armstrong, Ruth
AU - Sansbury, Francis H.
AU - Burke, Katherine B.
AU - Fry, Andrew E.
AU - Ragge, Nicola
AU - Sharif, Saba
AU - Foster, Alison
AU - De Sandre-Giovannoli, Annachiara
AU - Elouej, Sahar
AU - Vasudevan, Pradeep
AU - Mansour, Sahar
AU - Wilson, Kate
AU - Stewart, Helen
AU - Heide, Solveig
AU - Nava, Caroline
AU - Keren, Boris
AU - Demirdas, Serwet
AU - Brooks, Alice S.
AU - Vincent, Marie
AU - Isidor, Bertrand
AU - Küry, Sebastien
AU - Schouten, Meyke
AU - Leenders, Erika
AU - Chung, Wendy K.
AU - Haeringen, Arie van
AU - Scheffner, Thomas
AU - Debray, Francois Guillaume
AU - White, Susan M.
AU - Palafoll, Maria Irene Valenzuela
AU - Pfundt, Rolph
AU - Newbury-Ecob, Ruth
AU - Kleefstra, Tjitske
N1 - Acknowledgements: We are grateful to the patients and their families for their cooperation. This study makes use of data generated by the DECIPHER Consortium. A full list of centres who contributed to the generation of the data is available from https://decipher.sanger.ac.uk/ and via email from decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust and by grants from the Netherlands Organization for Health Research and Development (ZonMw grant 91718310 and the Dutch Scientific Organization (NWO, grant NWA 1160.18.320). WKC is supported by grants from SFARI and the JPB Foundation
Funding Information:
DDD statement The DDD study presents independent research commissioned by the Health Innovation Challenge Fund [grant number
Publisher Copyright: © 2021, The Author(s).
PY - 2021/1/12
Y1 - 2021/1/12
N2 - Witteveen-Kolk syndrome (OMIM 613406) is a recently defined neurodevelopmental syndrome caused by heterozygous loss-of-function variants in SIN3A. We define the clinical and neurodevelopmental phenotypes related to SIN3A-haploinsufficiency in 28 unreported patients. Patients with SIN3A variants adversely affecting protein function have mild intellectual disability, growth and feeding difficulties. Involvement of a multidisciplinary team including a geneticist, paediatrician and neurologist should be considered in managing these patients. Patients described here were identified through a combination of clinical evaluation and gene matching strategies (GeneMatcher and Decipher). All patients consented to participate in this study. Mean age of this cohort was 8.2 years (17 males, 11 females). Out of 16 patients ≥ 8 years old assessed, eight (50%) had mild intellectual disability (ID), four had moderate ID (22%), and one had severe ID (6%). Four (25%) did not have any cognitive impairment. Other neurological symptoms such as seizures (4/28) and hypotonia (12/28) were common. Behaviour problems were reported in a minority. In patients ≥2 years, three were diagnosed with Autism Spectrum Disorder (ASD) and four with Attention Deficit Hyperactivity Disorder (ADHD). We report 27 novel variants and one previously reported variant. 24 were truncating variants; three were missense variants and one large in-frame gain including exons 10–12.
AB - Witteveen-Kolk syndrome (OMIM 613406) is a recently defined neurodevelopmental syndrome caused by heterozygous loss-of-function variants in SIN3A. We define the clinical and neurodevelopmental phenotypes related to SIN3A-haploinsufficiency in 28 unreported patients. Patients with SIN3A variants adversely affecting protein function have mild intellectual disability, growth and feeding difficulties. Involvement of a multidisciplinary team including a geneticist, paediatrician and neurologist should be considered in managing these patients. Patients described here were identified through a combination of clinical evaluation and gene matching strategies (GeneMatcher and Decipher). All patients consented to participate in this study. Mean age of this cohort was 8.2 years (17 males, 11 females). Out of 16 patients ≥ 8 years old assessed, eight (50%) had mild intellectual disability (ID), four had moderate ID (22%), and one had severe ID (6%). Four (25%) did not have any cognitive impairment. Other neurological symptoms such as seizures (4/28) and hypotonia (12/28) were common. Behaviour problems were reported in a minority. In patients ≥2 years, three were diagnosed with Autism Spectrum Disorder (ASD) and four with Attention Deficit Hyperactivity Disorder (ADHD). We report 27 novel variants and one previously reported variant. 24 were truncating variants; three were missense variants and one large in-frame gain including exons 10–12.
UR - http://www.scopus.com/inward/record.url?scp=85100190831&partnerID=8YFLogxK
U2 - 10.1038/s41431-020-00769-7
DO - 10.1038/s41431-020-00769-7
M3 - Article
C2 - 33437032
AN - SCOPUS:85100190831
SN - 1018-4813
VL - 29
SP - 625
EP - 636
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 4
ER -